alcohol and glp 1 medications GLP-1 medications: The next big thing in use disorder treatment? β Recovery Research Institute π¨ Think GLP-1 medications make
Description
GLP-1 medications arent always the best first choice for small weight loss
It represents a fundamental shift in how obesity should be treated in clinical practice
PlexusDx explains the interaction risks, what clinical evidence shows, and how compounded tirzepatide may offer personalized options for weight management during breast cancer treatment

$LLY -0.60% today as Lilly's Mounjaro (tirzepatide), a GIP/GLP-1 dual receptor agonist, reduced A1C by an average of 2.2% in a Phase 3 trial of children and adolescents with type 2 diabetes More Info:

Read more about our research collaboration here: | 11 comments on LinkedIn
